Roche, SHL Telemedicine, Swatch, Swisscom May Move: Swiss Equity Preview
The following companies’ shares may be active in Zurich. Stock symbols are in parentheses after company names. Prices are from the last close.
Roche Holding AG (ROG VX): The world’s biggest maker of cancer drugs said partner Chugai received notification from Japanese regulators that the conditions for approval of the Actemra medicine have been lifted. The shares gained 1.4 percent to 138.9 Swiss francs.
SHL Telemedicine Ltd. (SHLTN SW): The Israeli provider of heart-monitoring services whose stock is traded in Switzerland confirmed its outlook for 2010 and reported second-quarter profit fell to $1.5 million from $1.6 million a year ago. The shares jumped 5.6 percent to 7.18 francs.
Swatch Group AG (UHR VX): The maker of Omega and Breguet timepieces, said profit rose 55 percent in the first half of the year as revenue hit a record.
Net income jumped to 462 million francs ($443 million) in the first half from 299 million francs in the same period a year earlier, the Biel, Switzerland-based company said. The shares slipped 0.3 percent to 327.5 francs.
Swisscom AG (SCMN VX): Switzerland’s largest phone company reported a second-quarter profit of 493 million francs. That compares to the 498.8 million-franc estimate of analysts surveyed by Bloomberg. The shares dropped 0.1 percent to 395.1 francs.
To contact the reporter on this story: Julie Cruz in Frankfurt at firstname.lastname@example.org